Cargando…
Efficient Presentation of Multiple Endogenous Epitopes to Both CD4(+) and CD8(+) Diabetogenic T Cells for Tolerance
Antigen-specific immunotherapy of type 1 diabetes, typically via delivery of a single native β cell antigen, has had little clinical benefit to date. With increasing evidence that diabetogenic T cells react against multiple β cell antigens, including previously unappreciated neo-antigens that can be...
Autores principales: | Dastagir, Shamael R., Postigo-Fernandez, Jorge, Xu, Chunliang, Stoeckle, James H., Firdessa-Fite, Rebuma, Creusot, Rémi J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363322/ https://www.ncbi.nlm.nih.gov/pubmed/28344989 http://dx.doi.org/10.1016/j.omtm.2016.12.002 |
Ejemplares similares
-
Nanoparticles versus Dendritic Cells as Vehicles to Deliver mRNA Encoding Multiple Epitopes for Immunotherapy
por: Firdessa-Fite, Rebuma, et al.
Publicado: (2019) -
Preclinical evaluation of a precision medicine approach to DNA vaccination in type 1 diabetes
por: Postigo-Fernandez, Jorge, et al.
Publicado: (2022) -
Epitope-based precision immunotherapy of Type 1 diabetes
por: Firdessa Fite, Rebuma, et al.
Publicado: (2023) -
Soluble antigen arrays improve the efficacy and safety of peptide-based tolerogenic immunotherapy
por: Firdessa-Fite, Rebuma, et al.
Publicado: (2023) -
Lysosomal cathepsin creates chimeric epitopes for diabetogenic CD4 T cells via transpeptidation
por: Reed, Brendan, et al.
Publicado: (2020)